StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was $11.77B, up 18.4% from the year before. Over ten years it grew 19.4% a year on average. The highest annual figure on record is $11.77B in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.77B+18.4%
FY2024Dec 31, 2024$9.94B+10.6%
FY2023Dec 31, 2023$8.98B+3.1%
FY2022Dec 31, 2022$8.72B+78.9%
FY2021Dec 31, 2021$4.87B+26.9%
FY2020Dec 31, 2020$3.84B+92.9%
FY2019Dec 31, 2019$1.99B+26.3%
FY2018Dec 31, 2018$1.58B-30.1%
FY2017Dec 31, 2017$2.25B-16.6%
FY2016Dec 31, 2016$2.70B+35.2%
FY2015Dec 31, 2015$2.00B–

More AstraZeneca figures

See a number that looks wrong?